Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Sickle cell community scrambles to find safe plan
Pfizer pulls sickle cell drug oxbryta, raising safety concerns
Pfizer’s abrupt withdrawal of Oxbryta, a drug for sickle cell disease, has sent shockwaves through the medical community.
Sickle cell community scrambles to find safe plan after a drug is pulled from the market
After Pfizer withdrew its sickle cell drug from the market, patients with the condition and their doctors were left scrambling to figure out what to do.
Pfizer Recalls All of Its Sickle Cell Disease Treatment Over Safety Concerns
Key Takeaways Pfizer is withdrawing all of its sickle cell disease drug, Oxbryta, worldwide because of safety concerns.The drug maker said the benefits of Oxbryta no longer outweigh the risks.The company's data indicated patients could suffer from severe pain and even death.
3d
on MSN
Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say
Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed ...
BioSpace
3d
Pfizer Takes Sickle Cell Drug Oxbryta Off Global Market, Cites Risk of Death
Based on new safety signals, Pfizer on Wednesday announced that Oxbryta’s overall benefit “no longer outweighs the risk” in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Grammy-winning singer dies
Helene death toll rises
Actor John Ashton dies
'Days of Our Lives' star dies
Vance’s Pennsylvania rally
Rescue mission launched
Hospitalized for burns
'SNL' launches 50th season
Newsom vetoes AI safety bill
Temporary outage fixed
NC small plane crash
‘Wild Robot' tops box office
Congestion fee bid denied
Malibu coast earthquake
Steward CEO to step down
Houthis attack US warships
Chief adviser subpoenaed
Faces fine to end Brazil ban
Ukrainian drones shot down
121st loss of the season
ISR airstrike kills Qaouk
Congressional Gold Medal
Haney sues Garcia
Ga. chemical plant fire
Condemns Israeli strikes
Earth's orbit new asteroid
Dow closes at record high
37 militants killed in Syria
UNC digital IDs blocked
Human rabies death in MN
Feedback